United States v. Lan Thi Tran Nguyen , 502 F. App'x 678 ( 2012 )


Menu:
  •                                                                            FILED
    NOT FOR PUBLICATION                            DEC 20 2012
    MOLLY C. DWYER, CLERK
    UNITED STATES COURT OF APPEALS                     U .S. C O U R T OF APPE ALS
    FOR THE NINTH CIRCUIT
    UNITED STATES OF AMERICA,                        No. 11-50238
    Plaintiff - Appellee,            D.C. No. 8:09-cr-00115-CJC-1
    v.
    MEMORANDUM *
    LAN THI TRAN NGUYEN,
    Defendant - Appellant.
    Appeal from the United States District Court
    for the Central District of California
    Cormac J. Carney, District Judge, Presiding
    Argued and Submitted December 7, 2012
    Pasadena, California
    Before: IKUTA and NGUYEN, Circuit Judges, and BURNS, District Judge.**
    Appellant Lan Thi Tran Nguyen, a pharmacist, appeals her conviction for
    distribution of pseudoephedrine knowing or having reasonable cause to believe it
    would be used to manufacture methamphetamine, in violation of 21 U.S.C.
    *
    This disposition is not appropriate for publication and is not precedent
    except as provided by 9th Cir. R. 36-3.
    **    The Honorable Larry A. Burns, District Judge for the U.S. District
    Court for the Southern District of California, sitting by designation.
    § 84l(c)(2). Nguyen contends that the district court gave an incorrect jury
    instruction, abused its discretion in admitting certain testimony from government
    witnesses, and improperly denied her motion for a mistrial based on the
    government’s alleged burden-shifting during closing arguments.
    We have jurisdiction under 
    28 U.S.C. § 1291
     and we affirm.
    1.     Nguyen contends that the district court erred in giving the jury the
    following instruction:
    “Reasonable cause to believe” means to have knowledge
    of facts which, although not amounting to direct
    knowledge, would cause a reasonable person knowing
    the same facts, to reasonably conclude that the
    pseudoephedrine would be used to manufacture a
    controlled substance.
    We have upheld this identical instruction in other prosecutions under
    § 841(c)(2).1 See United States v. Kaur, 
    382 F.3d 1155
    , 1156–57 (9th Cir. 2004);
    United States v. Johal, 
    428 F.3d 823
    , 827 (9th Cir. 2005) (reaffirming Kaur).
    Moreover, because the correct standard for criminal liability under § 841(c)(2)
    “incorporates both subjective and objective considerations,” Johal, 
    428 F.3d at 825
    , the district court properly rejected Nguyen’s proposed instruction, which
    “effectively equated reasonable cause to believe with actual knowledge.” Kaur,
    1
    This instruction is now discussed in the Comment section to Ninth Circuit Model
    Criminal Jury Instruction No. 9.28 (2010).
    -2-
    
    382 F.3d at 1157
    . Accordingly, the district court did not abuse its discretion in
    giving the challenged jury instruction.2
    2.     Nguyen challenges numerous evidentiary rulings made by the district
    court with regard to the testimony of Joan Coyne, a witness from the California
    Board of Pharmacy (the “Board”). A district court has wide latitude in making
    evidentiary rulings, United States v. Gilley, 
    836 F.2d 1206
    , 1213 (9th Cir. 1988);
    United States v. Hinkson, 
    585 F.3d 1247
    , 1251 (9th Cir. 2009) (en banc), and we
    find no abuse of discretion here.
    Coyne’s testimony did not lack sufficient foundation because it was based
    on her personal knowledge. Further, given Coyne’s background as a pharmacist,
    her position on the Board, and her fifteen years of experience investigating
    violations of pharmacy law, the district court did not err in allowing her to testify
    as an expert witness. See Fed. R. Evid. 702.
    Coyne’s testimony was also relevant and admissible under Federal Rules of
    Evidence 402 and 403, respectively. The evidence was relevant to whether
    Nguyen knew or had reasonable cause to believe that pseudoephedrine could be
    2
    Our conclusion is unaffected by our recent decision in United States v. Munguia,
    — F.3d —, No. 10–50253, 
    2012 WL 5937544
     (9th Cir. 2012), which, among other
    factual distinctions, involved a different instruction than the instruction given by
    Judge Carney in this case. Moreover, the Munguia panel reaffirmed Kaur and
    Johal, both of which dictate the outcome here.
    -3-
    used to make methamphetamine. Coyne made it abundantly clear that she had no
    personal knowledge as to whether Nguyen actually read the newsletters, thus
    ameliorating the danger of unfair prejudice. Further, because Coyne did not “draw
    the ultimate inference or conclusion for the jury and the ultimate inference or
    conclusion does not necessarily follow from the testimony[,]” United States v.
    Morales, 
    108 F.3d 1031
    , 1038 (9th Cir. 1997) (en banc), admission of this
    testimony did not violate Federal Rule of Evidence 704(b).
    3.     The district court did not abuse its discretion in admitting recorded
    statements made by a confidential informant during a controlled buy from Nguyen
    because the statements were not inadmissible hearsay. They were not offered to
    prove the truth of the matter asserted (that the informant was going to give the
    drugs to friends in San Jose who were going to make methamphetamine), but
    rather to show that Nguyen had knowledge or reasonable cause to believe that the
    cold medicine she sold would be used to manufacture methamphetamine. See Fed.
    R. Evid. 801(c).
    4.     Moreover, even if the district court had erred with respect to any
    evidentiary ruling, such error would be harmless. At trial, the government
    presented ample, if not overwhelming, additional evidence supporting Nguyen’s
    conviction, including: testimony and records showing that, as a CVS employee,
    -4-
    Nguyen had received training about the potentially illicit uses of pseudoephedrine;
    a disproportionately large quantity of drugs containing pseudoephedrine found in
    her pharmacy; a pseudoephedrine sales log containing false entries found at the
    front counter of her pharmacy; a partially-highlighted FDA printout discussing the
    legal limits on sales of pseudoephedrine found by the front desk; and inconsistent
    and/or untrue statements Nguyen made to law enforcement at the time of her arrest
    (for instance, that she did not sell products containing pseudoephedrine). See
    generally Morales, 
    108 F.3d at 1040
     (harmless error review applies to non-
    constitutional error; an appellate court must reverse unless there is a “fair assurance
    of harmlessness or, stated otherwise, unless it is more probable than not that error
    did not materially affect the verdict”).
    5.     Finally, the district court properly denied Nguyen’s motion for a
    mistrial. The prosecutor’s reference to the defense’s subpoena power, made during
    closing argument in response to defense counsel’s comments about the
    government’s failure to call certain witnesses, was not improper. See United States
    v. Cabrera, 
    201 F.3d 1243
    , 1250 (9th Cir. 2000) (holding that “a prosecutor’s
    comment on a defendant’s failure to call a witness does not shift the burden of
    proof … so long as the prosecutor does not violate the defendant’s Fifth
    -5-
    Amendment rights by commenting on the defendant’s failure to testify.”).3
    Further, both the prosecutor and defense counsel repeatedly reminded the jury that
    the government had the burden of proof. Under these facts, we find that no
    improper burden-shifting occurred. See United States v. Tucker, 
    641 F.3d 1110
    ,
    1122 (9th Cir. 2011); see also United States v. Semikian, 307 F. App’x 107, 109
    (9th Cir. 2009); United States v. Resendez-Ceballos, 255 F. App’x 110, 111 (9th
    Cir. 2007).
    AFFIRMED.
    3
    Since Nguyen testified in her own defense, no Fifth Amendment concerns are
    implicated.
    -6-